- Home
- DPRO vs IBIO Comparison
DPRO vs IBIO Comparison
Compare DPRO & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- IBIO
- Stock Information
- Founded
- DPRO 1998
- IBIO 2008
- Country
- DPRO Canada
- IBIO United States
- Employees
- DPRO N/A
- IBIO N/A
- Industry
- DPRO Aerospace
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- DPRO Industrials
- IBIO Health Care
- Exchange
- DPRO Nasdaq
- IBIO Nasdaq
- Market Cap
- DPRO 10.4M
- IBIO 9.3M
- IPO Year
- DPRO N/A
- IBIO N/A
- Fundamental
- Price
- DPRO $1.77
- IBIO $0.77
- Analyst Decision
- DPRO Strong Buy
- IBIO Strong Buy
- Analyst Count
- DPRO 2
- IBIO 3
- Target Price
- DPRO $6.00
- IBIO $4.87
- AVG Volume (30 Days)
- DPRO 247.4K
- IBIO 776.1K
- Earning Date
- DPRO 05-08-2025
- IBIO 05-02-2025
- Dividend Yield
- DPRO N/A
- IBIO N/A
- EPS Growth
- DPRO N/A
- IBIO N/A
- EPS
- DPRO N/A
- IBIO N/A
- Revenue
- DPRO $4,716,450.00
- IBIO $375,000.00
- Revenue This Year
- DPRO $94.01
- IBIO $36.00
- Revenue Next Year
- DPRO $95.14
- IBIO N/A
- P/E Ratio
- DPRO N/A
- IBIO N/A
- Revenue Growth
- DPRO 7.90
- IBIO 650.00
- 52 Week Low
- DPRO $1.55
- IBIO $0.64
- 52 Week High
- DPRO $7.01
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- DPRO 39.67
- IBIO 30.08
- Support Level
- DPRO $1.63
- IBIO $0.70
- Resistance Level
- DPRO $1.93
- IBIO $0.83
- Average True Range (ATR)
- DPRO 0.11
- IBIO 0.06
- MACD
- DPRO 0.02
- IBIO 0.08
- Stochastic Oscillator
- DPRO 46.67
- IBIO 41.18
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.